je.st
news
Tag: xarelto
Xarelto and Internal Bleeding Side Effects
2015-07-16 10:07:35| Chemicals - Topix.net
Patients undergoing surgery and those with atrial fibrillation who take Xarelto to reduce their risk of blood clots and stroke may be at risk for severe internal bleeding injuries, according to a growing body of research examining the potential side effects of the widely-used anticoagulant drug... Patients undergoing surgery and those with atrial fibrillation who take Xarelto to reduce their risk of blood clots and stroke may be at risk for severe internal bleeding injuries, according to a growing body of research examining the potential side effects of the widely-used anticoagulant drug.
Tags: side
effects
internal
bleeding
Bayer Seeking Dismissal of Out of State Xarelto Cases
2015-01-28 01:46:17| Chemicals - Topix.net
More than a dozen Xarelto cases have been filed in Philadelphia, alleging injuries and defendants' failure to warn of risk associated with the drug. Defendants in several Xarelto lawsuits filed by out of state plaintiffs have moved to dismiss the cases , asserting that circumstances surrounding the alleged injuries and Defendants' development and marketing of the anticoagulant have no connection to the state court venue where they were filed.
Tags: state
cases
seeking
bayer
Xarelto Suits Sent to Louisiana
2014-12-23 16:03:53| Chemicals - Topix.net
Xarelto is a new generation anticoagulant in a class of drugs known as direct thrombin inhibitors. It is a blood thinner used to reduce the risk of blood clots and strokes.
Germany's Bayer to launch three new Xarelto trials
2014-08-29 21:55:12| Chemicals - Topix.net
Germany's Bayer unveiled plans to launch three new studies to expand the uses of its anti-clotting drug Xarelto, one of its top five new medicines.
Tags: launch
trials
bayer
germanys
Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO
2014-08-29 21:55:11| Chemicals - Topix.net
Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO to include additional high-risk patient populations.
Tags: research
program
global
explorer